Literature DB >> 24899966

Ovarian mass mimicking malignancy: a case report.

Yong-Il Kim1, Seok-Ki Kim2, Jeong-Won Lee1, Sang Mi Lee1, Tae-Sung Kim1.   

Abstract

A 32-year-old female who suffered from abdominal pain underwent (18)F-fluorodexoyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnostic workup of pelvic mass lesions. Cystic mass lesions in the bilateral ovaries showed wall thickening and intense hypermetabolism along the rim. In addition, multifocal intense hypermetabolic lymphadenopathies were seen in the left paraaortic lymph node (LN), aortocaval LN, and both common iliac LNs. We interpreted these findings as bilateral ovarian cancer with retroperitoneal metastatic lymphadenopathies rather than endometriosis with reactive lymphadenopathies. However, histopathological examination confirmed the ovarian mass lesions as tubo-ovarian abscesses. We report a case that even if simultaneous hypermetabolic retroperitoneal LNs are seen, intense hypermetabolic lesions in both ovaries can be in consequence of inflammatory change.

Entities:  

Keywords:  Ovary; PET/CT; Retroperitoneal lymph node; Tubo-ovarian abscess

Year:  2010        PMID: 24899966      PMCID: PMC4042925          DOI: 10.1007/s13139-010-0045-9

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  16 in total

1.  18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma.

Authors:  Jennifer Ames; Todd Blodgett; Carolyn Meltzer
Journal:  AJR Am J Roentgenol       Date:  2005-10       Impact factor: 3.959

2.  Gallbladder tuberculosis: false-positive PET diagnosis of gallbladder cancer.

Authors:  J M Ramia; K Muffak; A Fernández; J Villar; D Garrote; J A Ferron
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

3.  Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers.

Authors:  Sadahiko Nishizawa; Masayuki Inubushi; Hiroyuki Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-14       Impact factor: 9.236

4.  FDG-PET for management of cervical and ovarian cancer.

Authors:  Laura J Havrilesky; Shalini L Kulasingam; David B Matchar; Evan R Myers
Journal:  Gynecol Oncol       Date:  2005-04       Impact factor: 5.482

5.  Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer.

Authors:  O Drieskens; S Stroobants; M Gysen; G Vandenbosch; L Mortelmans; I Vergote
Journal:  Gynecol Obstet Invest       Date:  2003       Impact factor: 2.031

6.  Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.

Authors:  Jun Konishi; Koichi Yamazaki; Eriko Tsukamoto; Nagara Tamaki; Yuya Onodera; Toshiyuki Otake; Toshiaki Morikawa; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Masaharu Nishimura
Journal:  Respiration       Date:  2003 Sep-Oct       Impact factor: 3.580

7.  Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.

Authors:  O S AAssar; N J Fischbein; G R Caputo; M J Kaplan; D C Price; M I Singer; W P Dillon; R A Hawkins
Journal:  Radiology       Date:  1999-01       Impact factor: 11.105

8.  Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.

Authors:  Hedva Lerman; Ur Metser; Dan Grisaru; Ami Fishman; Gennady Lievshitz; Einat Even-Sapir
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

9.  Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

Authors:  Robert J Downey; Tim Akhurst; David Ilson; Robert Ginsberg; Manjit S Bains; Mithat Gonen; Heng Koong; Marc Gollub; Bruce D Minsky; Maureen Zakowski; Alan Turnbull; Steven M Larson; Valerie Rusch
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

Review 10.  False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient.

Authors:  S-H Liu; J T Chang; S-H Ng; S-C Chan; T-C Yen
Journal:  Br J Radiol       Date:  2004-03       Impact factor: 3.039

View more
  6 in total

1.  F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.

Authors:  Hye Lim Park; Ie Ryung Yoo; Joo Hyun O; Eun Ji Han; Sung Hoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-03       Impact factor: 4.553

2.  Bilateral Tubo-Ovarian Abscess Mimics Ovarian Cancer on MRI and (18)F-FDG PET/CT.

Authors:  Rajan Rakheja; William Makis; Marc Hickeson
Journal:  Nucl Med Mol Imaging       Date:  2011-06-30

3.  Importance of Defect Detectability in Positron Emission Tomography Imaging of Abdominal Lesions.

Authors:  Shozo Yamashita; Kunihiko Yokoyama; Masahisa Onoguchi; Haruki Yamamoto; Tetsu Nakaichi; Shiro Tsuji; Kenichi Nakajima
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

Review 4.  The impact of infection and inflammation in oncologic 18F-FDG PET/CT imaging.

Authors:  W Tania Rahman; Daniel J Wale; Benjamin L Viglianti; Danyelle M Townsend; Matthew S Manganaro; Milton D Gross; Ka Kit Wong; Domenico Rubello
Journal:  Biomed Pharmacother       Date:  2019-07-01       Impact factor: 6.529

Review 5.  Acute Findings on FDG PET/CT: Key Imaging Features and How to Differentiate Them from Malignancy.

Authors:  Yan Li; Spencer Behr
Journal:  Curr Radiol Rep       Date:  2020-09-12

6.  Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication.

Authors:  Sona Balogova; Emile Daraï; Lucia Noskovicova; Ludovit Lukac; Jean-Noël Talbot; Françoise Montravers
Journal:  Clin Nucl Med       Date:  2022-04-01       Impact factor: 7.794

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.